Boston, MA (PRWEB) May 22, 2011
Attorney Christopher Drabik joins Furman Gregory Deptula's (FGD) intellectual property and patent law practice. He will be based in the firm’s Boston office.
Mr. Drabik's practice includes intellectual property counseling, licensing transactions and patent prosecution. Mr. Drabik has extensive experience in technology evaluation and freedom to operate analyses; providing legal support and guidance related to in and out-licensing of potential therapeutic agents; and drafting and negotiating collaboration, licensing, material transfer and other pharma/biotech-related agreements.
Prior to joining FGD, he served as legal counsel at an early stage pharma company with CNS drug candidates in phase I and phase II clinical trials. Mr. Drabik also brings to FGD his experience as a patent examiner at the USPTO, where he examined applications in the arts of gene therapy, transgenic animals and transgenic plants. Mr. Drabik earned his Master’s degree in molecular biology performing research related to understanding the effects of chromatin structure and DNA topology on transcription and he has more than ten years of research experience in academic and pharma industry labs. He is admitted in Massachusetts and the US Patent and Trademark Office.
“Chris has been working in bio start ups and has a great prospective that will serve our firm’s clients well,” states Karin Gregory, Managing Partner.
About Furman Gregory Deptula
Furman Gregory Deptula, with offices in Boston, MA, and Biddeford, ME, provides emerging growth companies with experienced business and legal advice. FGD represents clients in the areas of technology, software, biotech, medical devices, diagnostics, specialty food, telecom, and internet as well as the creative arts, retail and services sectors. The firm also provides expert corporate and regulatory advice to health care and research institutions and other non-profit organizations throughout the New England region.
# # #